SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gland Pharma informs about transcript of earnings conference call

21 May 2021 Evaluate

In continuation to its intimation dated April 12, 2021, regarding the Earnings Conference Call, Gland Pharma has informed that it has enclosed the details of the Transcript of the Earnings Conference Call on the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2021.

The above information is a part of company’s filings submitted to BSE.

Gland Pharma Share Price

1798.00 0.05 (0.00%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×